Workup of Suspected Sarcoidosis on HRCT Chest
For patients with suspected sarcoidosis on HRCT without classic clinical syndromes (Löfgren's, lupus pernio, or Heerfordt's), obtain tissue diagnosis via endobronchial ultrasound-guided lymph node sampling (EBUS) to confirm nonnecrotizing granulomas and exclude alternative diagnoses like tuberculosis and lymphoma.
Diagnostic Approach Algorithm
Step 1: Assess Clinical Presentation
First, determine if the patient has high clinical suspicion features that may obviate biopsy 1:
- Löfgren's syndrome (bilateral hilar lymphadenopathy + erythema nodosum + arthritis)
- Lupus pernio (chronic violaceous skin lesions on nose, cheeks, ears)
- Heerfordt's syndrome (fever, parotid enlargement, uveitis, facial nerve palsy)
If any of these classic syndromes are present: Biopsy is NOT recommended; proceed directly to baseline testing with close clinical follow-up 1.
If these syndromes are absent: Tissue diagnosis is essential to confirm sarcoidosis and exclude mimics.
Step 2: Obtain Tissue Diagnosis
Preferred method: EBUS-guided lymph node sampling 1
- Diagnostic yield: 87% (95% CI, 84-91%)
- Confirms sarcoidosis in 98% of diagnostic samples
- Identifies critical alternative diagnoses (38% tuberculosis, 25% lymphoma among alternatives)
- Complication rate: <0.1%
- Superior safety profile compared to mediastinoscopy
Alternative if EBUS unavailable: Mediastinoscopy has higher diagnostic yield (98%) but greater invasiveness 1.
Critical caveat: Even with typical bilateral hilar lymphadenopathy on imaging, 11% of patients have alternative diagnoses—most commonly tuberculosis and lymphoma 1. This underscores why tissue diagnosis matters for patient safety and appropriate treatment.
Step 3: Baseline Laboratory Screening
Once sarcoidosis is confirmed (or presumed in classic syndromes), obtain the following baseline tests 1:
Mandatory testing:
- Serum calcium (strong recommendation) - screens for abnormal calcium metabolism that can cause nephrolithiasis and renal damage 1
- Serum creatinine - screens for renal sarcoidosis 1
- Serum alkaline phosphatase - screens for hepatic sarcoidosis 1
Optional testing:
- Serum transaminases (no recommendation for or against) 1
- Both 25-OH and 1,25-OH vitamin D levels if vitamin D replacement is being considered 1
Step 4: Cardiac Screening
For asymptomatic patients without cardiac symptoms:
- Obtain baseline ECG (conditional recommendation) 1
- Do NOT routinely perform transthoracic echocardiography or 24-hour Holter monitoring 1
If cardiac symptoms or ECG abnormalities present:
- Cardiac MRI is the preferred test for suspected cardiac involvement 1
- If cardiac MRI unavailable, use dedicated PET scan rather than echocardiography 1
Rationale: Cardiac sarcoidosis carries significant mortality risk, but routine screening with echo/Holter in asymptomatic patients has low yield. ECG provides adequate initial screening 1.
Step 5: Pulmonary Hypertension Screening
Screen with transthoracic echocardiography if ANY of the following are present 1:
- Exertional chest pain or syncope
- Prominent P2 or S4 on exam
- Reduced 6-minute walk distance
- Desaturation with exercise
- Reduced DLCO
- Enlarged pulmonary artery on CT (PA diameter > ascending aorta)
- Elevated BNP
- Fibrotic lung disease on HRCT
If echo suggests PH: Confirm with right heart catheterization 1
If echo does NOT suggest PH but clinical suspicion remains high: Right heart catheterization should be considered case-by-case 1.
Key Pitfalls to Avoid
Don't skip biopsy in asymptomatic bilateral hilar lymphadenopathy without classic syndromes - 11% have alternative diagnoses including life-threatening conditions like lymphoma 1
Don't forget baseline calcium testing - this is the only strong recommendation in the guidelines and prevents serious complications from hypercalcemia 1
Don't over-screen for cardiac disease in asymptomatic patients - ECG is sufficient; routine echo/Holter not recommended 1
Don't assume normal chest imaging excludes pulmonary sarcoidosis - in suspected cardiac sarcoidosis, 40% with normal chest CT had positive lung biopsies 2
Evidence Quality Note
All recommendations from the 2020 American Thoracic Society guidelines are based on very low-quality evidence, reflecting the heterogeneous nature of sarcoidosis and lack of high-quality trials 1. However, these represent the most current and authoritative consensus from systematic reviews by multidisciplinary experts using GRADE methodology.